AUS
NZ
UK
CA
USA
IND
Healthcare
THC Stock Zooms Up By 8.14% On Receiving Two Major Cannabis Permits
December 21, 2018 08:05 PM AEDT| By Team Kalkine MediaAs per the ASX announcement dated 21st December 2018, the THC Global Group Limited (ASX: THC), formerly The Hydroponics Company Ltd, announces approval of two major cannabis permits by its wholly owned subsidiary Canndeo Limited. The receipt of grant...
Genetic Technologies Announces JV With Blockshine Technology
December 21, 2018 03:14 PM AEDT| By Team Kalkine MediaAs per ASX announcement on 21st December 2018, Genetic Technologies Limited (ASX: GTG) has signed a joint venture with Blockshine Technology Corporation (BTC), via its subsidiary Gene Ventures Pty Ltd. The combined company ?Blockshine Health? is expe...
Healthscope Provided All Due Diligence Materials To Brookfield With Regards to Brookfield’s Proposal
December 21, 2018 02:18 PM AEDT| By Team Kalkine MediaOn 21 December 2018, leading private healthcare provider Healthscope Limited (ASX: HSO) ?provided an update about the proposal from Brookfield Capital Partners Limited which was announced on 12 November 2018. In the announcement, Brookfield has confi...
4 Health Care Stocks - PAB, VHT, OSL And IMU
December 20, 2018 10:52 PM AEDT| By Team Kalkine MediaAt the time when the markets are oscillating like never, health care stock in such situations plays an important role. Few of the stocks which are up and chose to close in green are from the health care sector. Let?s look at them in brief below. PATR...
Starpharma’s VivaGel® BV Will Now Be Seen On US Shelves
December 20, 2018 10:42 PM AEDT| By Team Kalkine MediaStarpharma authorized the US-based pharmaceutical company ITF Pharma to sell and market its novel VivaGel? BV in the United States. In an announcement dated 20 December 2018, Starpharma Holdings Limited (ASX: SPL) told that it had signed a license wi...
Biotech Giant, Dimerix Obtains R&D Tax Rebate For FY18
December 20, 2018 10:37 PM AEDT| By Team Kalkine MediaAs per recent ASX announcement, biotechnology company Dimerix Limited (ASX: DXB) shared its success in obtaining Research & Development tax rebate for the 2017-2018 financial year amounting to $1,073,628, boosting company?s efforts and expenditur...
Hemp’s Removal Creates Growth Opportunities For Creso Pharma Limited - What Investors Need To Know
December 20, 2018 07:44 PM AEDT| By Team Kalkine MediaOn December 20, 2018, Creso Pharma Limited (ASX: CPH) has made an announcement that its brands can now be introduced in the human as well as animal health markets of the US. The information was given with the help of the press release. As per the ann...
Althea Group Receives Its Largest Medicinal Cannabis Shipment From Canadian Aphria Inc
December 20, 2018 04:27 PM AEDT| By Team Kalkine MediaAs per today?s ASX announcement, medical cannabis company Althea Group Holdings Limited (ASX: AGH) successfully received its largest cannabis shipment to date, from Canadian supplier Aphria Inc. With the shipment, it is anticipated that Althea?s inve...
Impression Healthcare Signs MOU With A Canadian Cannabis Oil Producer
December 20, 2018 03:31 PM AEDT| By Team Kalkine MediaImpression Healthcare Limited (ASX: IHL) is the largest home dental impression company in Australia providing its consumers laboratory-grade and personalized dental healthcare products at their homes. The products are available at a meagre price as c...
BWX Nosedives Over 40% After Revising Its Profit Guidance
December 20, 2018 01:19 PM AEDT| By Team Kalkine MediaAustralian branded product company, BWX Limited (ASX: BWX) has revised its expected normalized EBITDA guidance for FY19 from earlier disclosed $40.3 million to now $27m-$32m. The company also informed that in the first half of FY19, the company is ex...
Telix’s Shares Uplifted On ASX After Completing First And Second Stage Consultation With PMDA
December 19, 2018 11:31 PM AEDT| By Team Kalkine MediaGlobal biopharmaceutical company Telix Pharmaceuticals Limited (ASX: TLX) made an announcement on 19 December 2018 stating that it has completed the first and second stage consultations with the Japanese Pharmaceuticals and Medical Devices Agency (PM...
Phosphagenics Agreed On Settlement With Mylan – Stock Price Ramped Up 300 Percent on ASX
December 19, 2018 07:06 PM AEDT| By Team Kalkine MediaPhosphagenics Limited (ASX: POH) is a Melbourne-based biotechnology company focused on the development, sale and licensing of pharmaceutical and nutraceutical products. The company has via a recent ASX release stated that a full and final settlement...
Clinuvel Pharmaceuticals Shares Impressive Results For Vitiligo CUV103 Phase II Study
December 19, 2018 05:25 PM AEDT| By Team Kalkine MediaClinuvel Pharmaceuticals Ltd (ASX: CUV) is a leading biomedical company focusing its R&D on the treatment of phototoxicity and skin related ailments in adults. Its product offerings are in diverse areas that include photomedicine, pharmacology, p...
THC Asks ASX For A Trading Halt Of Its Securities Till 21 December 2018
December 19, 2018 05:24 PM AEDT| By Team Kalkine MediaTHC Global Group Limited (ASX: THC) which was earlier known as Hydroponics Company Ltd has asked ASX for the trading halt of its securities till Friday 21 December 2018 or in case any further announcement is made by the company as per the ASX Listing...
Alcidion Group Limited Signs Contract Extension For Support Services To ACT Health
December 19, 2018 03:35 PM AEDT| By Team Kalkine MediaFor two years, the company has announced that its subsidiary MKM Health has renewed its ongoing support contract with ACT Health. From January 1, 2019, to December 31, 2020, the contract will run, and the contract extension is valued at $1.27 million...
LifeSpot Health Inked A Deal With CBDS Health For Its First Commercial Sales And Distribution
December 19, 2018 03:22 PM AEDT| By Team Kalkine MediaLifeSpot Health Limited (ASX: LSH) is into the digital healthcare sector. It works on developing and commercializing medical diagnostic & monitoring technology. The company has smart-phone based systems and applications. The company in the proces...
Cynata Therapeutics Shares Clinical Study Results On Phase 1- CYP001
December 18, 2018 07:21 PM AEDT| By Team Kalkine MediaCynata Therapeutics Limited (ASX: CYP) is a biotechnology company based out in Victoria, Australia. The company is engaged in developing Cymerus technology, a therapeutic stem cell, in collaboration with the University of Wisconsin-Madison (UWM), a r...
Positive Phase 2B Clinical Trial Results For iPPS Boost Paradigm’s Shares
December 18, 2018 04:09 PM AEDT| By Team Kalkine MediaThe Australian biopharmaceutical company, Paradigm Biopharmaceuticals? (ASX: PAR) shares went up by 12.5 percent today (i.e., 18 December 2018) after the company announced positive results from its phase 2B clinical trial of injectable pentosan polys...
Botanix Pharmaceuticals Obtains Ethics Approval: BTX 1204 Phase 2 Atopic Dermatitis Study
December 18, 2018 03:48 PM AEDT| By Team Kalkine MediaAs per recent ASX announcement on 18th December, biopharmaceutical?company Botanix Pharmaceuticals Limited (ASX: BOT) was successful in obtaining ethics approval for its BTX 1204 Phase 2 atopic dermatitis study. The company will now begin with recrui...
$3.2 Million Successful Capital Placement By Respiri
December 18, 2018 03:37 PM AEDT| By Team Kalkine MediaRespiri Limited (ASX: RSH), a healthcare company, provides new technologies that help people in managing asthma and detecting wheeze, COPD, and various respiratory diseases. Today, the company has declared that it has been able to conduct a $3.2 mil...
Advertise your brand on Kalkine Media